These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15826289)

  • 1. [Antimycotic drugs under continuous renal replacement therapy].
    Muhl E
    Mycoses; 2005; 48 Suppl 1():56-60. PubMed ID: 15826289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
    Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
    G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.
    Bergner R; Hoffmann M; Riedel KD; Mikus G; Henrich DM; Haefeli WE; Uppenkamp M; Walter-Sack I
    Nephrol Dial Transplant; 2006 Apr; 21(4):1019-23. PubMed ID: 16311263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
    Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
    ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of continuous renal replacement therapy in acute renal failure.
    Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M;
    Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy.
    Betrus C; Remenapp R; Charpie J; Kudelka T; Brophy P; Smoyer WE; Lin JJ
    Ann Thorac Cardiovasc Surg; 2007 Dec; 13(6):378-83. PubMed ID: 18292719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs dosing in intensive care unit during continuous renal replacement therapy].
    Bourquin V; Ponte B; Saudan P; Martin PY
    Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications for continuous renal function replacement therapy].
    Kes P; Ljutić D; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2003; 57(1):71-5. PubMed ID: 12876869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
    Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival to discharge among patients treated with continuous renal replacement therapy.
    Wald R; Deshpande R; Bell CM; Bargman JM
    Hemodial Int; 2006 Jan; 10(1):82-7. PubMed ID: 16441832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous renal replacement therapy does not have a clear role in the treatment of poisoning.
    Kim Z; Goldfarb DS
    Nephron Clin Pract; 2010; 115(1):c1-6. PubMed ID: 20173343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute renal failure in critically ill patients].
    Toft P; Gilsaa T
    Ugeskr Laeger; 2007 Feb; 169(8):692-5. PubMed ID: 17313917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
    Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL
    Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous renal replacement therapies (CRRT)].
    Canepari G; Inguaggiato P; Gigliola G; Bainotti S; Formica M
    G Ital Nefrol; 2006; 23 Suppl 36():S30-7. PubMed ID: 17068727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.